Shares of Nutrien Ltd (NTR) recently traded at $62.89, surpassing the average 12-month analyst target price of $62.16. This movement raises questions about potential analyst actions, such as downgrades or increases in target prices, based on the company’s performance and market trends.
Currently, 19 analysts contribute to Nutrien’s price targets, with estimates ranging from a low of $56.00 to a high of $70.00. The standard deviation among these targets is $3.933. As of now, the analyst ratings breakdown indicates 10 strong buy ratings, 2 buy ratings, 7 hold ratings, and 1 strong sell rating, with an average rating of 2.0 (on a scale where 1 is strong buy and 5 is strong sell).
This data suggests a generally positive outlook among analysts, even as investors must evaluate whether the recent price increase reflects continued growth potential or an overvaluation.
